IDDM
| | | | | |
Crall 197869 | Postmortem | IDDM | 9 | % of vessel length narrowed | 47% had >50% arterial length narrowing compared with 1% control |
Valsania 199153 | CA | IDDM; age and symptom matched to non-diabetic controls undergoing clinically indicated CA | 32 | Number of vessels with significant stenosis (>70% considered significant) | More multivessel disease |
Pajunen 200054 | CA | IDDM; patients undergoing CA for suspected CAD individually matched to controls for various parameters | 64 | QCA to measure % of vessel involved and most severe stenosis (%); atheroma burden; Gensini score | More severe extensive and distal disease |
NIDDM
|
Calton 199544 | CA | NIDDM; individually matched | 75 | Coronary score | Higher scores; three vessel disease more common; no more diffuse disease |
Hamby 197941 | CA | NIDDM and IGT | 100 | Coronary score | Higher coronary scores and more three vessel disease (difference seen only in those with hypertriglyceridaemia) |
Natali 200035 | CA | NIDDM | Analysis of 2253 consecutive patients | Coronary score | More three vessel disease; higher coronary score; greater effect on female diabetic patients |
Pajunen 199748 | CA | NIDDM; clinically indicated angiography; individually matched | 57 | QCA to measure % of vessel involved and most severe stenosis (%); atheroma burden; Gensini score | No difference |
Vigorita 198031 | Postmortem | “Adult onset” DM; individually matched for age and sex | 185 | Number of coronary vessels with significant (stenosis >75%) reduction in luminal area | More multivessel disease |
Waller 198036 | Postmortem | Onset of DM after age 30 | 229 | Number of coronary vessels with significant (stenosis >75%) reduction in luminal area | More LMS; no difference in number of stenoses between groups |
Thomas 200252 | CA | NIDDM; comparison with 23 non-diabetic patients; unmatched | 59 | QCA | More severe and distal disease |
Waldecker 199934 | CA | NIDDM presenting with acute MI; compared with 358 controls | 46 | Location and severity of culprit lesion; number of diseased vessels | More multivessel disease |
IDDM and NIDDM
|
Abadie 198349 | CA | All DM; patients with “severe ischaemic heart disease” | 36 | Coronary score | No difference in coronary score or number of vessels involved |
Cariou 200043 | CA | All DM; clinically indicated CA; matched for age and sex | 50 | Number of significant stenoses (>50%) | More significant stenoses; no difference in number of vessels involved or diffuse or distal disease; more LMS disease |
Dortimer 197832 | CA | All DM; individually matched for age, sex, and high or low risk factor status | 37 | Coronary score | Increased coronary score; no more diffuse disease. |
Hochman 198850 | Postmortem | All DM; specimens examined from patients with suspected CAD | 25 | Number of significant stenoses (>75%) | No difference |
Melidonis 199933 | CA | All DM; patients with angiographically determined CAD were included and matched to controls | 463 | Number of diseased vessels; location of disease;. luminal width | More three vessel disease; more RCA |
Wilson 198347 | CA | All DM; matched to non-diabetic controls | 58 | Number of major and minor lesions | More major stenoses; more intermediate segment disease |